Free Trial

ORIC Pharmaceuticals (ORIC) Earnings Date, Estimates & Call Transcripts

ORIC Pharmaceuticals logo
$5.25 +0.08 (+1.53%)
As of 10:28 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ORIC Pharmaceuticals Earnings Summary

Upcoming
Earnings Date
May. 5Before Market OpensEstimated
Consensus EPS
(Feb. 18)
-$0.52
Actual EPS
(Feb. 18)
-$0.51 Beat By $0.01

ORIC Pharmaceuticals issued Q4 2024 earnings on February 18, 2025, reporting an EPS of -$0.51, which topped analysts' consensus estimates of -$0.52 by $0.01. With a trailing EPS of -$1.82, ORIC Pharmaceuticals' earnings are expected to grow next year, from ($2.17) to ($1.96) per share.

Q4 2024 Earnings Resources

ORIC Upcoming Earnings

ORIC Pharmaceuticals' Q1 2025 earnings is scheduled for Monday, May 5, 2025, with a conference call scheduled on Wednesday, May 7, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get ORIC Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ORIC Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ORIC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORIC Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.53-$0.50-$0.52
Q2 20252-$0.55-$0.49-$0.52
Q3 20252-$0.57-$0.48-$0.53
Q4 20252-$0.58-$0.48-$0.53
FY 20258($2.23)($1.95)($2.09)

ORIC Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2025
(Estimated)
--------
2/18/2025Q4 2024-$0.52-$0.51+$0.01-$0.51--
11/12/2024--$0.48-$0.49 -$0.01-$0.49--
8/12/2024Q2 2024-$0.42-$0.45 -$0.03-$0.45--
5/6/2024Q1 2024-$0.44-$0.37+$0.07-$0.37--
3/11/2024--$0.49-$0.49--$0.49--
11/6/2023Q3 2023-$0.46-$0.44+$0.02-$0.44--
8/10/2023Q2 2023-$0.58-$0.50+$0.08-$0.50--
5/8/2023Q1 2023-$0.54-$0.53+$0.01-$0.53--

ORIC Pharmaceuticals Earnings - Frequently Asked Questions

ORIC Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on ORIC's earnings history.

In the previous quarter, ORIC Pharmaceuticals (NASDAQ:ORIC) reported ($0.51) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.52) by $0.01. Learn more on analysts' earnings estimate vs. ORIC's actual earnings.

ORIC Pharmaceuticals (NASDAQ:ORIC) has a recorded net income of -$100.70 million. ORIC has generated -$1.82 earnings per share over the last four quarters.

ORIC Pharmaceuticals's earnings are expected to grow from ($2.17) per share to ($1.96) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ORIC) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners